| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |